Skip to main content

Beam Therapeutics Inc 10-Q for FY2024 Q3

Beam Therapeutics Inc. (BEAM)

10-Q 2024-11-05 For: 2024-09-30
View Original
Added on April 09, 2026

About this 10-Q

Beam Therapeutics Inc filed this 10-Q on November 5, 2024, covering the quarter ended September 30, 2024 (FY2024 Q3).

Headline figures

Quarter ended September 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$14.27M
down 17.0% from $17.19M a year earlier
Net loss
$96.67M
compared with a net loss of $96.09M a year earlier
Diluted EPS
-$1.17
compared with -$1.22 a year earlier